SequelSEC

Agentix Corp. AGTX

Biological Products, (No Diagnostic Substances) · CIK 0001603345 · Fiscal year ends 0331

Revenue
$0
Fiscal year ended 2023-03-31
Operating income
-$1.37M
Fiscal year ended 2023-03-31
Free cash flow
Unavailable
Fiscal year ended 2023-03-31

Agentix Corp. (AGTX) reported revenue of $0 and net income of -$1.37M for the fiscal year ended 2023-03-31. This page shows 6 annual periods of income statement, balance sheet and cash flow figures normalized from Agentix Corp.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Biological Products, (No Diagnostic Substances).

Income

Agentix Corp. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-312022-03-312021-08-312017-08-312016-08-312015-08-31
Revenue$0$1.24K$1.24K$2.25K$43.14K$28.38K
Cost of revenue$0$561$561$1.36K$1.36K$2.04K
Gross profit$0$679$679$893$41.79K$26.34K
Operating income-$1.37M-$2.63M-$1.34M-$333.99K-$292.43K-$175.13K
Net income-$1.37M-$2.63M-$1.34M-$381.10K-$295.64K-$175.13K
Research & development$711.51K$279.91K$365.13KUnavailable$3.69K$28.33K
Weighted-average diluted sharesUnavailableUnavailableUnavailableUnavailableshares 6.02Mshares 5.96M
Pretax income-$1.37MUnavailable-$1.34M-$381.10K-$295.64KUnavailable
Income tax expense$0$0$0UnavailableUnavailableUnavailable
Diluted EPSUnavailableUnavailableUnavailableUnavailable$-0.05$-0.03
Selling, general & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
General & administrative$140.01K$165.36K$66.42K$23.68K$23.01K$36.26K
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Agentix Corp. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-312022-03-312021-08-312017-08-312016-08-312015-08-31
Cash & equivalents$12.37K$145$1.77K$3.69K$619$13.20K
Total assets$261.39K$15.98K$51.21K$7.09K$1.29K$17.52K
Current assets$261.39K$15.98K$51.21K$3.69K$619$13.20K
Total liabilities$2.51M$1.09M$606.94K$72.17K$3.69KUnavailable
Current liabilities$2.51M$1.09M$606.94K$4.74K$3.69K$7.37K
Total equity incl. NCI-$2.25M-$1.08M-$555.74K-$65.08K-$2.40K$10.15K
Temporary (mezzanine) equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
InventoryUnavailableUnavailable$49.44KUnavailableUnavailableUnavailable
Accounts receivableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
GoodwillUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debtUnavailableUnavailableUnavailable$89.00KUnavailableUnavailable
Accounts payable$1.06M$145.12K$121.24KUnavailable$2.80KUnavailable

Cash flow

Agentix Corp. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-312022-03-312021-08-312017-08-312016-08-312015-08-31
Operating cash flow-$88.54K-$25.20K-$420.98K-$76.42K-$12.58K-$186.92K
Capital expendituresUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Investing cash flow$0$0$0-$9.52KUnavailableUnavailable
Financing cash flow$100.00K$0$180.00K$89.00KUnavailable$65.30K
Net change in cash$12.22K-$25.20K-$240.98K$3.07K-$12.58K-$121.62K
Stock-based compensationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchasesUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Depreciation & amortizationUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Derived

Agentix Corp. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2023-03-312022-03-312021-08-312017-08-312016-08-312015-08-31
Free cash flowUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Gross marginUnavailable54.8%54.8%39.7%96.9%92.8%
Operating marginUnavailable-211825.1%-108147.7%-14844.0%-677.8%-617.2%
FCF marginUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
SBC / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Current ratio0.10x0.01x0.08x0.78x0.17x1.79x
Revenue YoY growth-100.0%UnavailableUnavailable-94.8%52.0%Unavailable
Net marginUnavailable-211825.1%-108092.5%-16937.8%-685.2%-617.2%
R&D / revenueUnavailable22573.5%29446.1%Unavailable8.6%99.8%
CapEx / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Long-term debt / equityUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open AGTX in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-10View SEC filing
10-K · Filed 2026-07-01View SEC filing
10-Q · Filed 2026-02-17View SEC filing
10-Q · Filed 2025-11-20View SEC filing
10-Q · Filed 2025-08-22View SEC filing
10-K · Filed 2025-07-16View SEC filing

Companies in the same industry

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.